© 1998 by European Society of Cardiology
Copyright © 1998, European Society of Cardiology
Long acting calcium antagonist amlodipine prevents left ventricular remodeling after myocardial infarction in rats
aFirst Department of Internal Medicine, Osaka City University Medical School, Osaka 545, Japan
bDepartment of Pharmacology, Osaka City University Medical School, Osaka 545, Japan
* Corresponding author. Tel. (+81-6) 645 2106; Fax (+81-6) 645 2107.
Objective: The purpose of this study was to examine the effect of amlodipine, a long-acting calcium antagonist, on the left ventricular remodeling, including systolic and diastolic dysfunction, the change of cardiac gene expression in the myocardial infarcted rats (MI). Methods: On the first day after myocardial infarction, the animals were randomly assigned to amlodipine treatment (n=8) or untreated groups (MI; n=9). We then performed Doppler-echocardiographic examinations and measured the hemodynamics at four weeks after myocardial infarction. Following these measurements, their cardiac mRNA was analyzed. Results: Left ventricular end-diastolic pressure (LVEDP) and central venous pressure (CVP) increased to 22±1 mmHg and 5±1 mmHg. Amlodipine reduced LVEDP and CVP to 15±1 mmHg (P<0.01) and 3±0 mmHg (P<0.01). The weight of right ventricle in MI was significantly larger than in the control rats (Control; 0.48±0.01 g/kg, MI; 0.79±0.04 g/kg, P<0.01). Left ventricular end-diastolic dimension (LVDd) in MI increased to 10.3±0.3 mm (P<0.01) (Control; 6.2±0.3 mm). Amlodipine prevented an increase of the weight of right ventricle (0.62±0.03 g/kg, P<0.01) and LVDd (7.9±0.2 mm, P<0.01 to MI). The rats in MI showed systolic dysfunction shown by the decreased fractional shortening (Control; 31±2% versus MI; 15±1%, P<0.01), and diastolic dysfunction shown by E wave deceleration rate (Control; 18.1±2.0 m/s2, MI; 32.6±2.1 m/s2, P<0.01). Amlodipine significantly prevented systolic and diastolic dysfunction. The increases in β-MHC, 
-skeletal actin, and ANP mRNAs in the non-infarcted left ventricle and right ventricle at four weeks after the myocardial infarction were all significantly suppressed by the treatment with amlodipine. On the other hand, depressed -MHC was restored to normal levels by amlodipine in both regions. Conclusions: Amlodipine prevents the left ventricular remodeling process accompanied by systolic and diastolic dysfunction, and inhibits abnormal cardiac gene expression after myocardial infarction.
KEYWORDS Ventricular remodeling; Myocardial infarction; Calcium channel antagonists; Echocardiography; Gene expression
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Ogino, G. Takemura, H. Kanamori, H. Okada, R. Maruyama, S. Miyata, M. Esaki, M. Nakagawa, T. Aoyama, H. Ushikoshi, et al. Amlodipine inhibits granulation tissue cell apoptosis through reducing calcineurin activity to attenuate postinfarction cardiac remodeling Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2271 - H2280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. I. Jugdutt and V. Menon Beneficial Effects of Therapy on the Progression of Structural Remodeling During Healing After Reperfused and Nonreperfused Myocardial Infarction: Different Effects on Different Parameters Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2002; 7(2): 95 - 107. [Abstract] [PDF]
|
|
|
|
 |
|
 B. I. Jugdutt, V. Menon, D. Kumar, and H. Idikio Vascular remodeling during healing after myocardial infarction in the dog model: Effects of reperfusion, amlodipine and enalapril J. Am. Coll. Cardiol., May 1, 2002; 39(9): 1538 - 1545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kumamoto, H. Okamoto, M. Watanabe, H. Onozuka, K. Yoneya, I. Nakagawa, S. Chiba, S. Watanabe, T. Mikami, K. Abe, et al. Beneficial effect of myocardial angiogenesis on cardiac remodeling process by amlodipine and MCI-154 Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1117 - H1123. [Abstract] [Full Text] [PDF]
|
|